AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas –immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

1 North Waukegan Road
North Chicago, IL 60064

Visit website

Stock Symbol: ABBV
Stock Exchange: NYSE

Together, we break through.

Our principles are at the Heart of our Company. Operating as one AbbVie team, we care deeply for our patients, their families, our employees, and our communities. We strive to always do the right thing, pursuing the highest standards in quality, compliance, safety, and performance. In everything we do, we invest and innovate relentlessly to tackle unmet needs, creating new medicines and healthcare approaches for a healthier world.

How we work with each other and achieve results matters. That’s why we’ve been honored to receive some of the most prestigious ratings and recognitions in the industry, including being named on more than 40 Great Place to Work and Top Employer lists and FORTUNE “100 Best Companies to Work For.”

Click here to learn more about our principles.

NEWS

Drug Development

Novartis’ Cosentyx Narrowly Misses Beating Out AbbVie’s Humira in Arthritis Trial

Novartis is careful to note that Cosentyx showed “numerically higher results versus Humira,” and that there are some statistically significant advantages of the drug over Humira.

November 1, 2019

3 min read

Mark Terry

Business

Disc Medicine Closes $50 Million Series A and Inks Licensing Deal with AbbVie

Disc Medicine is focused on hepcidin biology to restore red blood cell production in hematologic diseases.

October 29, 2019

3 min read

Mark Terry

BioMed X Completes Alzheimer’s Disease Research Project

BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease.

October 28, 2019

2 min read

Business

Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie

AbbVie will work to develop a cystic fibrosis transmembrane conductance regulator potentiator compound that it licensed from the Foundation.

October 24, 2019

2 min read

Mark Terry

Business

Generational Priorities: What Baby Boomers, Gen-Xers and Millennials Think Makes an Ideal Employer

When it comes to specific attributes, having the opportunity to do interesting and meaningful work, securing a competitive salary and having access to quality health benefits were the most important. Here are some differences when it comes to generational priorities.

October 21, 2019

3 min read

Porschia Parker

Employer Resources

Employees’ Perception vs. Employers’ Reality! New Research Shows the Top 3 Areas of Opportunity

What makes an organization a desirable employer? Do they need to be a large company with a recognizable name? Should the organization pay their employees more than others?

October 11, 2019

4 min read

Porschia Parker

Business

AbbVie Stays Busy While Working to Complete Allergan Acquisition

As the $63 billion acquisition of Allergan by Chicago-based AbbVie slowly churns through the Federal Trade Commission (FTC) process, the company continues to make the news. Here’s a look.

October 11, 2019

3 min read

Mark Terry

BioMidwest

Top 20 Pharma Companies by Market Cap in Q1 2019

GlobalData recently published their top 20 global pharma companies categorized by market capitalization in the first quarter of 2019.

October 9, 2019

6 min read

Mark Terry

FDA

Expanded Approval for AbbVie’s Mayvret Shortens Treatment Time for Some HCV Patients

AbbVie’s Mayvret won expanded approval from the U.S. Food and Drug Administration to shorten the one-daily treatment duration from 12 to eight weeks in treatment-naïve hepatitis C patients without cirrhosis and with compensated cirrhosis.

September 27, 2019

2 min read

Alex Keown

JOBS